Cargando...
Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures
OBJECTIVE: Intravenous (IV) levetiracetam (LEV) is approved for use in patients older than 16 years and may be useful in critically ill children, although there is little data available regarding pharmacokinetics. We aim to investigate the safety, an appropriate dosing, and efficacy of IV LEV in cri...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2009
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2946960/ https://ncbi.nlm.nih.gov/pubmed/19325512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PCC.0b013e3181a0e1cf |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|